Plain-English translation of NCT07068620 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Cerebral small vessel disease is the most common vascular cause of cognitive decline and dementia in older adults, yet doctors still lack clear tools to predict who will develop dementia or how to treat it effectively. This study uses brain wave recordings (EEG) and cognitive training exercises—some personalized by artificial intelligence—to understand how these brain changes affect thinking and memory. The researchers hope to identify early warning signs that could help prevent or slow cognitive decline.
Right now, when doctors find small vessel disease on brain scans, they often have no specific treatment to offer, representing a major missed opportunity for prevention. This study aims to fill that gap by discovering brain activity patterns that could predict who is at highest risk and whether targeted cognitive training can help protect thinking and memory skills.
You likely qualify if…
You likely don't qualify if…
You will undergo brain wave recordings (EEG) to measure electrical activity in your brain, then participate in cognitive training exercises—either personalized ones adapted by artificial intelligence or traditional step-by-step training. Some participants will also receive mild electrical brain stimulation (tACS) combined with training. The study will assess how these interventions affect your brain activity and cognitive performance, helping researchers understand which approaches work best for people with small vessel disease.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France